Diuretic Drugs Market to Register CAGR of 5.44%, Increasing Incidence of Hypertension in People to Drive Growth

NEW YORK, September 29, 2022 /PRNewswire/ — The “Diuretic Drugs Market by Product Type and Geography – Forecast and Analysis 2022-2026” report has been added to Technavio’s offerings. The market size is expected to increase by $95.64 million from 2021 to 2026. Further, the growth momentum of the market will accelerate at a CAGR of 5.44% during the forecast period.

Technavio has announced its latest market research report titled Global Diuretic Drugs Market 2022-2026

Technavio provides a comprehensive summary of the report outlining the market size and forecast along with the research methodology. The FREE sample report is available in PDF format

Market factors

The increased incidence of hypertension due to increasing pressure on artery walls is driving the market growth. High blood pressure increases the risk of diseases such as kidney failure, stroke and heart disease. It can also affect the brain causing stroke, TIA, dementia, or mild cognitive impairment. The prevalence of hypertension in low- and middle-income countries is high. Hypertension has no warning signs or symptoms. Hence, he is also known as the silent killer. It can also cause bone loss, sexual dysfunction, and conditions like obstructive sleep apnea (OSA). Thus, increasing number of patients with hypertension due to obesity, diabetes, CKD, stress, sedentary lifestyle, and alcohol dependence will drive the market growth over the course of the forecast period.

Supplier Landscape

The diuretic market is concentrate, and suppliers are deploying growth strategies such as R&D investments to compete in the market. Competition among vendors is high due to the rapid growth in sales of some diuretics. Besides, a strong pipeline of drugs to treat high blood pressure and edema will further intensify the competition during the forecast period. The market will register the approvals of several promising drugs, which will intensify the competition among the sellers.

Company Profiles

The Diuretics Market report includes information on product launches, sustainability and outlook of key vendors including AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Novartis AG, Monarch Pharmachem, Pfizer Inc., Padagis US LLC, Sanofi, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., VITARIS AG, Validus Pharmaceuticals LLC and Zydus Lifesciences Ltd.

Technavio reports provide key strategic initiatives used by suppliers, as well as key news and latest developments. View our FREE sample PDF report now

Competitive analysis

The report includes competitive analysis, a proprietary tool to assess and analyze the position of companies based on their industry position score and market performance score. The tool uses different factors to categorize players into categories such as growth strategies, financial performance over the past three years, new product launches, innovation score, market share growth, investments , etc.

Market segmentation

  • By product type, the market has been categorized into loop diuretics, thiazide diuretics, and others. The loop diuretic drugs will contribute the largest market share over the forecast period.

  • By geography, the market has been categorized into North America, Europe, Asiaand Rest of the World (ROW). North America will have the largest market share during the forecast period.

Discover the contribution of each segment summarized in concise infographics and detailed descriptions. See a sample FREE PDF report

Related Reports

Motion Sickness Drugs Market by Product and Geography – Forecast and Geography 2022-2026: Motion Sickness Drugs Market Expected to Grow by $119.64 million from 2021 to 2026.

Antihypertensive Drugs Market by Type and Geography – Forecast and Analysis 2022-2026: The Antihypertensive Drugs Market Share is Expected to Grow by $5.87 billion from 2021 to 2026.

Diuretic Drugs Market Scope

Report cover

Details

Page number

120

Year of reference

2021

Forecast period

2022-2026

Growth momentum and CAGR

Accelerate at a CAGR of 5.44%

Market Growth 2022-2026

$95.64 million

Market structure

Concentrate

Annual growth (%)

4.29

Regional analysis

North America, Europe, Asia and Rest of the World (ROW)

Successful market contribution

North America at 37%

Main consumer countries

United States, Canada, Denmark, China and India

Competitive landscape

Leading companies, competitive strategies, scope of consumer engagement

Profiled companies

AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Monarch Pharmachem, Novartis AG, Padagis US LLC, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, VITARIS AG and Zydus Lifesciences Ltd.

Market dynamics

Parent market analysis, market growth drivers and barriers, analysis of fast and slow growing segments, impact of COVID-19 and future consumer dynamics, and analysis of market conditions for the forecast period.

Personalization area

If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Browse Healthcare Market Reports

Contents

1. Summary

2 Market landscape

3 Market sizing

4 Five forces analysis

5 Market Segmentation by Product Type

6 Customer Landscape

7 Geographic landscape

8 drivers, challenges and trends

9 Supplier landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a global leader in technology research and consulting. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s reporting library consists of over 17,000 reports and counts, spanning 800 technologies, spanning 50 countries. Their customer base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market intelligence to identify opportunities in existing markets and potentials and assess their competitive positions in changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Global Diuretic Drugs Market 2022-2026

Global Diuretic Drugs Market 2022-2026

Quote

Quote

View original content to download multimedia: https://www.prnewswire.com/news-releases/diuretic-drugs-market-to-record-a-cagr-of-5-44-increasing-incidence-of-hypertension -among-people-to-energize-growth—technavio-301635779.html

SOURCETechnavio

Comments are closed.